Oliver Distler

11PUBLICATIONS

56CO-AUTHORS

Rheumatology and arthritisHaematologyImplementation science and evaluationGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 15, 2026

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

|Nov 14, 2025

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Javier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin

|Sep 05, 2023

Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

Elisabeth Deibel, Patricia E Carreira, Madelon Vonk

|Jul 25, 2023

Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.

Hanlin Yin, Oliver Distler, Lichong Shen

|May 27, 2021

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.

Nina M van Leeuwen, Maaike Boonstra, Jaap A Bakker

|Mar 24, 2021

Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.

Michał Rudnik, Filip Rolski, Suzana Jordan

Pageof 2

Frequent Collaborators

Christopher P Denton

Maria De Santis

Madelon Vonk

Jörg H W Distler

Gabriela Kania

Sophie Liem

Hans Ulrich Scherer

Carina Mihai

Maaike Boonstra

Jaap A Bakker

Frequent Collaborators

Christopher P Denton

Maria De Santis

Madelon Vonk

Jörg H W Distler